* Imunon Inc IMNN.OQ IMNN.O is expected to show a fall
in
quarterly revenue when it reports results on August 10.
*
* Refinitiv's mean analyst estimate for Imunon Inc is for a
loss
of 70 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts had fallen by
about 1.3%
in the last three months.
* Wall Street's median 12-month price target for Imunon Inc
is
$15, above its last closing price of $1.24.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Mar. 31 2023 -0.66 -0.66 -0.68 Missed -2.5
Dec. 31 2023 -0.85 -1.61 Missed -89.4
Sep. 30 2022 -0.79 -0.81 -0.87 Missed -7.4
Jun. 30 2022 -1.44 -1.12 -0.87 Beat 22.5
Mar. -0.99 -0.99 -1.82 Missed -83.8
31 2022
Dec. 31 2021 -0.90 -0.90 -3.62 Missed -302.2
Sep. 30 2021 -1.27 -1.20 -0.90 Beat 25
Jun. 30 2021 -1.20 -1.20 -0.90 Beat 25
This summary was machine generated August 8 at 14:39 GMT. All
figures in US dollars unless otherwise stated